Masimo (MASI) late Tuesday said Katie Szyman has been selected as the new chief executive officer at the medical device company, succeeding interim CEO Michelle Brennan, who was appointed to be the new chair of Masimo's board of directors.
Both moves take effect on Feb. 12, the company said.
Szyman currently is the worldwide president for advanced patient monitoring at Becton, Dickinson (BD) and previously led the critical care product group at Edwards Lifesciences before its acquisition by BD in September 2024.
Brennan temporarily became CEO at Masimo on Sept. 25 after Joe Kiani disclosed plans to step down from the company. The former Johnson & Johnson senior executive was elected to the Masimo board in 2023.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.